Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Balamurugan Tangiisuran, Ph.D.

Concepts (140)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists320202561.290 Why?
Malaysia1520221061.150 Why?
Community Pharmacy Services12020500.710 Why?
Health Knowledge, Attitudes, Practice3202039660.710 Why?
Household Products12018270.670 Why?
Nonprescription Drugs120201170.670 Why?
Accidents120181640.610 Why?
Poisoning120182530.590 Why?
Medication Therapy Management120171290.550 Why?
Pesticides120182910.540 Why?
Intention120183460.540 Why?
Nursing Staff120171300.540 Why?
Inappropriate Prescribing220142100.470 Why?
Long-Term Care120176110.440 Why?
Medication Adherence3201920990.430 Why?
Respiratory Tract Infections120209800.410 Why?
Hypoglycemia120198620.410 Why?
Delphi Technique120157980.400 Why?
Anti-Bacterial Agents2202072690.400 Why?
Hyperglycemia1201913800.360 Why?
Poisons22022360.360 Why?
Nursing Homes2201410440.340 Why?
Attitude of Health Personnel4201738710.310 Why?
Guideline Adherence2201522950.290 Why?
Nigeria220207640.290 Why?
Hypoglycemic Agents1201929750.280 Why?
Hospitalization52016104220.280 Why?
Caregivers1201721490.250 Why?
Renal Insufficiency, Chronic1201921910.250 Why?
Physicians2202146250.250 Why?
Disease Management1201524730.240 Why?
Cross-Sectional Studies92020254540.220 Why?
Models, Theoretical1201435860.210 Why?
Diabetes Mellitus, Type 232020119090.190 Why?
Emergency Service, Hospital2202077660.190 Why?
Drug Prescriptions2201016510.180 Why?
Adverse Drug Reaction Reporting Systems220174780.180 Why?
Nicotinic Agonists120222720.180 Why?
Polypharmacy120212980.170 Why?
Legislation, Drug120202100.160 Why?
Substance Withdrawal Syndrome120226250.150 Why?
Drugs, Chinese Herbal120191460.150 Why?
Algorithms22017139840.130 Why?
Homes for the Aged120172630.120 Why?
Perception2201911990.120 Why?
Antidepressive Agents2201728630.120 Why?
Quality of Life22019130440.110 Why?
Sex Distribution1201823040.110 Why?
Aged1320211656290.110 Why?
Male1820203543110.110 Why?
Needs Assessment1201811510.110 Why?
Databases as Topic120144750.110 Why?
Nutritional Support120141700.100 Why?
Qualitative Research1202127780.100 Why?
Humans2620227527410.100 Why?
Female1820203850900.100 Why?
Inpatients3201725490.100 Why?
Geriatric Assessment2201713900.100 Why?
Prevalence32019154040.100 Why?
General Practitioners120121060.090 Why?
Heart Failure12015110960.090 Why?
Nutrition Assessment120147290.090 Why?
Professional Competence120144490.090 Why?
Medication Reconciliation120121530.090 Why?
Aged, 80 and over72017583610.090 Why?
Patient Education as Topic1201922970.080 Why?
Depressive Disorder, Major2201746920.080 Why?
Retrospective Studies82022787580.080 Why?
Hospitals, University120105760.080 Why?
Europe1201433590.080 Why?
Antihypertensive Agents2202020830.070 Why?
Malnutrition120146310.070 Why?
Hospitals, Teaching1201211830.070 Why?
Prospective Studies52020538630.070 Why?
Stroke22020101520.070 Why?
Pilot Projects1202084130.070 Why?
Brain Ischemia1202032840.070 Why?
Risk Factors82020730940.070 Why?
Drug Utilization1201211800.070 Why?
Middle Aged920202160540.070 Why?
Follow-Up Studies22019392230.060 Why?
Primary Health Care1202146240.060 Why?
Continuity of Patient Care1201210560.060 Why?
Comorbidity22019104500.060 Why?
Incidence22020211460.060 Why?
Patient Discharge2201633560.060 Why?
Recurrence3202084220.050 Why?
Anxiety1201643950.050 Why?
Risk Assessment42020235540.050 Why?
Adult720222166580.050 Why?
Pulmonary Disease, Chronic Obstructive1201630770.050 Why?
Multivariate Analysis12014122500.050 Why?
Neuropsychological Tests1201470080.050 Why?
Child, Preschool22022413900.050 Why?
Quinoxalines120222880.050 Why?
Bupropion120223100.050 Why?
Benzazepines120223200.040 Why?
Reproducibility of Results22017200260.040 Why?
Epirubicin12019810.040 Why?
Prognosis12019292640.040 Why?
Antineoplastic Combined Chemotherapy Protocols12019116260.040 Why?
Obesity12020128680.040 Why?
Hypertension2202086140.040 Why?
Depression1201678760.030 Why?
Complementary Therapies120194850.030 Why?
Practice Guidelines as Topic1201273550.030 Why?
Fluorouracil1201916330.030 Why?
Registries2202082160.030 Why?
Pharmaceutical Preparations1202210870.030 Why?
Cyclophosphamide1201922520.030 Why?
Educational Status1202025730.030 Why?
Personnel, Hospital120142880.030 Why?
Child12020785940.020 Why?
Breast Neoplasms12019209140.020 Why?
Blood Pressure Monitoring, Ambulatory120122490.020 Why?
Aging1200987520.020 Why?
Myocardial Ischemia1202021520.020 Why?
Hospital Administration120123530.020 Why?
Time Factors22020401950.020 Why?
Life Style1201938610.020 Why?
Treatment Outcome32022640170.020 Why?
Health Status1201940770.020 Why?
Sex Factors12019104690.020 Why?
Nutritional Status1201416100.020 Why?
Smoking1202290300.020 Why?
Neoplasm Staging12019110910.010 Why?
Medication Errors120107990.010 Why?
Longitudinal Studies12019142190.010 Why?
Self Report1201436180.010 Why?
Body Mass Index12020128210.010 Why?
Infant, Newborn12022259030.010 Why?
Quality Indicators, Health Care1201218420.010 Why?
Patient Readmission1201631610.010 Why?
Sensitivity and Specificity12017147610.010 Why?
Hospitals1201439860.010 Why?
Infant12022354470.010 Why?
Cohort Studies12022409390.010 Why?
Disease Progression12016133640.010 Why?
Mass Screening1201452820.010 Why?
Adolescent12022867130.010 Why?
Tangiisuran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.